LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 119

Search options

  1. Article ; Online: There Will Be Blood: Not All AVM Complications Are Due to Radiation.

    Chen, Xuguang / Redmond, Kristin J

    International journal of radiation oncology, biology, physics

    2021  Volume 111, Issue 4, Page(s) 855

    MeSH term(s) Humans ; Intracranial Arteriovenous Malformations ; Radiosurgery/adverse effects
    Language English
    Publishing date 2021-10-14
    Publishing country United States
    Document type Letter ; Research Support, Non-U.S. Gov't
    ZDB-ID 197614-x
    ISSN 1879-355X ; 0360-3016
    ISSN (online) 1879-355X
    ISSN 0360-3016
    DOI 10.1016/j.ijrobp.2021.07.009
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Navigating the Spinal Frontier: Recent Data on Stereotactic Body Radiation Therapy for Spine Metastases.

    Redmond, Kristin J / Hattangadi-Gluth, Jona / Pollum, Erqi Liu / Trifiletti, Daniel M / Kim, Michelle M / Milano, Michael

    International journal of radiation oncology, biology, physics

    2024  Volume 118, Issue 2, Page(s) 313–317

    MeSH term(s) Humans ; Spine ; Radiosurgery ; Spinal Neoplasms/secondary
    Language English
    Publishing date 2024-01-14
    Publishing country United States
    Document type Editorial
    ZDB-ID 197614-x
    ISSN 1879-355X ; 0360-3016
    ISSN (online) 1879-355X
    ISSN 0360-3016
    DOI 10.1016/j.ijrobp.2023.11.015
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Recognition and Management of the Long-term Effects of Cranial Radiation.

    Shaaban, Sherif G / LeCompte, Michael C / Kleinberg, Lawrence R / Redmond, Kristin J / Page, Brandi R

    Current treatment options in oncology

    2023  Volume 24, Issue 7, Page(s) 880–891

    Abstract: Opinion statement: Cranial radiation is ubiquitous in the treatment of primary malignant and benign brain tumors as well as brain metastases. Improvement in radiotherapy targeting and delivery has led to prolongation of survival outcomes. As long-term ... ...

    Abstract Opinion statement: Cranial radiation is ubiquitous in the treatment of primary malignant and benign brain tumors as well as brain metastases. Improvement in radiotherapy targeting and delivery has led to prolongation of survival outcomes. As long-term survivorship improves, we also focus on prevention of permanent side effects of radiation and mitigating the impact when they do occur. Such chronic treatment-related morbidity is a major concern with significant negative impact on patient's and caregiver's respective quality of life. The actual mechanisms responsible for radiation-induced brain injury remain incompletely understood. Multiple interventions have been introduced to potentially prevent, minimize, or reverse the cognitive deterioration. Hippocampal-sparing intensity modulated radiotherapy and memantine represent effective interventions to avoid damage to regions of adult neurogenesis. Radiation necrosis frequently develops in the high radiation dose region encompassing the tumor and surrounding normal tissue. The radiographic findings in addition to the clinical course of the patients' symptoms are taken into consideration to differentiate between tissue necrosis and tumor recurrence. Radiation-induced neuroendocrine dysfunction becomes more pronounced when the hypothalamo-pituitary (HP) axis is included in the radiation treatment field. Baseline and post-treatment evaluation of hormonal profile is warranted. Radiation-induced injury of the cataract and optic system can develop when these structures receive an amount of radiation that exceeds their tolerance. Special attention should always be paid to avoid irradiation of these sensitive structures, if possible, or minimize their dose to the lowest limit.
    MeSH term(s) Adult ; Humans ; Quality of Life ; Neoplasm Recurrence, Local/etiology ; Cranial Irradiation/adverse effects ; Brain Neoplasms/diagnosis ; Brain Neoplasms/etiology ; Brain Neoplasms/radiotherapy ; Brain ; Radiation Injuries/diagnosis ; Radiation Injuries/etiology ; Radiation Injuries/therapy
    Language English
    Publishing date 2023-05-05
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 2057351-0
    ISSN 1534-6277 ; 1527-2729
    ISSN (online) 1534-6277
    ISSN 1527-2729
    DOI 10.1007/s11864-023-01078-z
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Neuro-oncology clinical trial locations and social vulnerability in the United States.

    Gomez, Gabriela T / Turner, Brandon E / Redmond, Kristin J / Deville, Curtiland / Perni, Subha

    Neuro-oncology practice

    2023  Volume 11, Issue 1, Page(s) 100–102

    Language English
    Publishing date 2023-10-20
    Publishing country England
    Document type Journal Article
    ZDB-ID 2768945-1
    ISSN 2054-2585 ; 2054-2577
    ISSN (online) 2054-2585
    ISSN 2054-2577
    DOI 10.1093/nop/npad062
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Stereotactic body radiation therapy for spinal metastases: A new standard of care.

    Sacino, Amanda N / Chen, Hanbo / Sahgal, Arjun / Bettegowda, Chetan / Rhines, Laurence D / Maralani, Pejman / Redmond, Kristin J

    Neuro-oncology

    2024  Volume 26, Issue 12 Suppl 2, Page(s) S76–S87

    Abstract: Advancements in systemic therapies for patients with metastatic cancer have improved overall survival and, hence, the number of patients living with spinal metastases. As a result, the need for more versatile and personalized treatments for spinal ... ...

    Abstract Advancements in systemic therapies for patients with metastatic cancer have improved overall survival and, hence, the number of patients living with spinal metastases. As a result, the need for more versatile and personalized treatments for spinal metastases to optimize long-term pain and local control has become increasingly important. Stereotactic body radiation therapy (SBRT) has been developed to meet this need by providing precise and conformal delivery of ablative high-dose-per-fraction radiation in few fractions while minimizing risk of toxicity. Additionally, advances in minimally invasive surgical techniques have also greatly improved care for patients with epidural disease and/or unstable spines, which may then be combined with SBRT for durable local control. In this review, we highlight the indications and controversies of SBRT along with new surgical techniques for the treatment of spinal metastases.
    MeSH term(s) Humans ; Radiosurgery ; Spinal Neoplasms/radiotherapy ; Standard of Care ; Pain
    Language English
    Publishing date 2024-03-05
    Publishing country England
    Document type Review ; Journal Article
    ZDB-ID 2028601-6
    ISSN 1523-5866 ; 1522-8517
    ISSN (online) 1523-5866
    ISSN 1522-8517
    DOI 10.1093/neuonc/noad225
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Treatment Planning Expansions in Glioblastoma: How Less Can Be More.

    Trifiletti, Daniel M / Milano, Michael T / Redmond, Kristin J / Pollom, Erqi L / Hattangadi-Gluth, Jona A / Kim, Michelle M

    International journal of radiation oncology, biology, physics

    2023  Volume 117, Issue 2, Page(s) 293–296

    MeSH term(s) Humans ; Glioblastoma/diagnostic imaging ; Glioblastoma/radiotherapy
    Language English
    Publishing date 2023-08-31
    Publishing country United States
    Document type Editorial ; Comment
    ZDB-ID 197614-x
    ISSN 1879-355X ; 0360-3016
    ISSN (online) 1879-355X
    ISSN 0360-3016
    DOI 10.1016/j.ijrobp.2023.03.062
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Radiotherapy after gross-total resection and subtotal resection of spinal chordoma: a SEER database analysis of overall survival outcomes.

    Gendreau, Julian / Kuo, Cathleen C / Mehkri, Yusuf / Chakravarti, Sachiv / Lu, Brian / Lubelski, Daniel / Redmond, Kristin J / Bettegowda, Chetan / Mukherjee, Debraj

    Journal of neurosurgery. Spine

    2023  Volume 39, Issue 3, Page(s) 411–418

    Abstract: Objective: Chordomas are most frequently found in the sacrum, vertebral column, and skull base. Achieving gross-total resection (GTR) has been shown to optimize overall survival (OS); however, the efficacy of radiotherapy (RT) for patients with GTR is ... ...

    Abstract Objective: Chordomas are most frequently found in the sacrum, vertebral column, and skull base. Achieving gross-total resection (GTR) has been shown to optimize overall survival (OS); however, the efficacy of radiotherapy (RT) for patients with GTR is currently not well understood. Given that RT may negatively impact patient quality of life, the aim of this study was to evaluate the utility of RT for improving OS in patients who have undergone GTR of spinal chordoma through analysis of the national Surveillance, Epidemiology, and End Results (SEER) database.
    Methods: The SEER database (1975-2018) was queried for all adult patients (≥ 21 years) who underwent GTR for spinal chordoma. Bivariate analysis was conducted using chi-square testing for categorical variables, and the log-rank test was performed to find the associations of clinical variables with OS. Cox proportional hazards models were generated for multivariate analyses of the associations among clinical variables and OS.
    Results: A total of 263 spinal chordomas that underwent GTR were identified. The mean age of all included patients was 58.72 years, and 63.9% of patients were male. In addition, 0.4% had dedifferentiated histology. The mean follow-up was 75.54 months. Of all patients, 152 (57.8%) received no RT and 111 (42.2%) received RT. Patients with sacral tumor location (80.9% vs 51.4%, p < 0.001) were more likely not to undergo RT when compared to patients with vertebral column location. In multivariate analysis, only age ≥ 65 years was associated with poorer OS (HR 3.16, CI 1.54-5.61, p < 0.001). RT did not have a statistically significant association with OS.
    Conclusions: RT after GTR of chordoma did not improve OS among SEER chordoma patients to a value that achieved statistical significance. Additional multicenter prospective studies are needed to determine the true efficacy of RT after GTR of spinal chordoma.
    MeSH term(s) Adult ; Humans ; Male ; Middle Aged ; Aged ; Female ; Chordoma/radiotherapy ; Chordoma/surgery ; Chordoma/pathology ; Quality of Life ; Radiotherapy, Adjuvant ; Sacrum/surgery ; Sacrum/pathology ; Retrospective Studies ; Treatment Outcome
    Language English
    Publishing date 2023-06-09
    Publishing country United States
    Document type Multicenter Study ; Journal Article
    ZDB-ID 2158643-3
    ISSN 1547-5646 ; 1547-5654
    ISSN (online) 1547-5646
    ISSN 1547-5654
    DOI 10.3171/2023.5.SPINE2396
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Clinical Outcomes After Stereotactic Body Radiation Therapy for Nonspinal Bone Metastases: A Systematic Review and Meta-analysis.

    Singh, Raj / Valluri, Anisha / Lehrer, Eric J / Cao, Yilin / Upadhyay, Rituraj / Trifiletti, Daniel M / Lo, Simon S / Redmond, Kristin J / Sahgal, Arjun / Nguyen, Quynh-Nhu / Palmer, Joshua D

    International journal of radiation oncology, biology, physics

    2024  

    Abstract: There are limited data available on clinical outcomes after stereotactic body radiation therapy (SBRT) for nonspinal bone metastases. We performed a systematic review and meta-analysis to characterize local control (LC), overall survival (OS), pain ... ...

    Abstract There are limited data available on clinical outcomes after stereotactic body radiation therapy (SBRT) for nonspinal bone metastases. We performed a systematic review and meta-analysis to characterize local control (LC), overall survival (OS), pain response rates, and toxicity after SBRT. The primary outcomes were 1-year LC, incidence of acute and late grade 3 to 5 toxicities, and overall pain response rate at 3 months. The secondary outcome was 1-year OS. The Newcastle-Ottawa scale was used for assessment of study bias, with a median score of 5 for included studies (range, 4-8). Weighted random-effects meta-analyses were conducted to estimate effect sizes. We identified 528 patients with 597 nonspinal bone lesions in 9 studies (1 prospective study and 8 retrospective observational studies) treated with SBRT. The estimated 1-year LC rate was 94.6% (95% CI, 87.0%-99.0%). The estimated 3-month combined partial and complete pain response rate after SBRT was 87.7% (95% CI, 55.1%-100.0%). The estimated combined acute and late grade 3 to 5 toxicity rate was 0.5% (95% CI, 0%-5.0%), with an estimated pathologic fracture rate of 3.1% (95% CI, 0.2%-9.1%). The estimated 1-year OS rate was 71.0% (95% CI, 51.7%-87.0%). SBRT results in excellent LC and palliation of symptoms with minimal related toxicity. Prospective investigations are warranted to further characterize long-term outcomes of SBRT for patients with nonspinal bone metastases.
    Language English
    Publishing date 2024-01-12
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 197614-x
    ISSN 1879-355X ; 0360-3016
    ISSN (online) 1879-355X
    ISSN 0360-3016
    DOI 10.1016/j.ijrobp.2023.12.051
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Characterizing the presentation, management, and clinical outcomes of patients with intradural spinal chordomas: a systematic review.

    Saint-Germain, Max A / Kramer, Patrick / Weber-Levine, Carly / Jiang, Kelly / Al-Mistarehi, Abdel-Hameed / Redmond, Kristin J / Lee, Sang H / Bettegowda, Chetan / Theodore, Nicholas / Lubelski, Daniel

    Neurosurgical focus

    2024  Volume 56, Issue 5, Page(s) E14

    Abstract: Objective: Chordomas are locally aggressive neoplasms of the spine or skull base that arise from embryonic remnants of the notochord. Intradural chordomas represent a rare subset of these neoplasms, and few studies have described intradural chordomas in ...

    Abstract Objective: Chordomas are locally aggressive neoplasms of the spine or skull base that arise from embryonic remnants of the notochord. Intradural chordomas represent a rare subset of these neoplasms, and few studies have described intradural chordomas in the spine. This review evaluates the presentation, management, and outcomes of intradural spinal chordomas.
    Methods: A systematic review of PubMed/MEDLINE, EMBASE, Cochrane Library, Scopus, and Web of Science was performed. Studies describing at least 1 case of intradural chordomas anywhere in the spine were included. Extracted details included presenting symptoms, radiological findings, treatment course, follow-up, and disease progression.
    Results: Thirty-one studies, with a total of 41 patients, were included in this review. Seventy-six percent (31/41) of patients had primary intradural tumors, whereas 24% (10/41) presented with metastasis. The most common signs and symptoms were pain (n = 27, 66%); motor deficits (n = 20, 49%); sensory deficits (n = 17, 42%); and gait disturbance (n = 10, 24%). The most common treatment for intradural chordoma was resection and postoperative radiotherapy. Sixty-six percent (19/29) of patients reported improvement or complete resolution of symptoms after surgery. The recurrence rate was 37% (10/27), and the complication rate was 25% (6/24). The median progression-free survival was 24 months (range 4-72 months). Four patient deaths were reported. The median follow-up time was 12 months (range 13 days-84 months).
    Conclusions: Treatment of intradural spinal chordomas primarily involves resection and radiotherapy. A significant challenge and complication in management is spinal tumor seeding after resection, with 9 studies proposing seeding as a mechanism of tumor metastasis in 11 cases. Factors such as tumor size, Ki-67 positivity, and distant metastasis may correlate with worse outcomes and demonstrate potential as prognostic indicators for intradural spinal chordomas. Further research is needed to improve understanding of this tumor and develop optimal treatment paradigms for these patients.
    MeSH term(s) Humans ; Chordoma/surgery ; Chordoma/diagnostic imaging ; Spinal Cord Neoplasms/surgery ; Spinal Cord Neoplasms/therapy ; Treatment Outcome ; Spinal Neoplasms/surgery ; Spinal Neoplasms/diagnostic imaging ; Disease Management
    Language English
    Publishing date 2024-05-01
    Publishing country United States
    Document type Systematic Review ; Journal Article
    ZDB-ID 2026589-X
    ISSN 1092-0684 ; 1092-0684
    ISSN (online) 1092-0684
    ISSN 1092-0684
    DOI 10.3171/2024.2.FOCUS2419
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: The Radiosurgery Society Case-Based Discussion of the Management of Head and Neck or Skull Base Paragangliomas with Stereotactic Radiosurgery and Radiotherapy.

    Ehret, Felix / Ebner, Daniel K / McComas, Kyra N / Gogineni, Emile / Andraos, Therese / Kim, Minsun / Lo, Simon / Schulder, Michael / Redmond, Kristin J / Muacevic, Alexander / Shih, Helen A / Kresl, John

    Practical radiation oncology

    2024  Volume 14, Issue 3, Page(s) 225–233

    Abstract: Stereotactic radiosurgery (SRS) and fractionated stereotactic radiotherapy (FSRT) have been used for the treatment of head and neck or skull base paraganglioma for a considerable time, demonstrating promising local control rates and a favorable safety ... ...

    Abstract Stereotactic radiosurgery (SRS) and fractionated stereotactic radiotherapy (FSRT) have been used for the treatment of head and neck or skull base paraganglioma for a considerable time, demonstrating promising local control rates and a favorable safety profile compared with surgical approaches. Nevertheless, the choice of treatment must be carefully tailored to each patient's preferences, tumor location, and size, as well as anticipated treatment-related morbidity. This case-based review serves as a practical and concise guide for the use of SRS and FSRT in the management of head and neck or skull base paragangliomas, providing information on the diagnosis, treatment, follow-up considerations, and potential pitfalls.
    MeSH term(s) Humans ; Radiosurgery/methods ; Paraganglioma/radiotherapy ; Paraganglioma/pathology ; Paraganglioma/surgery ; Skull Base Neoplasms/radiotherapy ; Skull Base Neoplasms/surgery ; Head and Neck Neoplasms/radiotherapy ; Head and Neck Neoplasms/surgery ; Male ; Middle Aged ; Female ; Aged ; Adult
    Language English
    Publishing date 2024-01-16
    Publishing country United States
    Document type Journal Article ; Case Reports ; Review
    ZDB-ID 2655748-4
    ISSN 1879-8519 ; 1879-8500
    ISSN (online) 1879-8519
    ISSN 1879-8500
    DOI 10.1016/j.prro.2023.12.011
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top